Antiviral therapy improves postoperative survival in patients with hepatocellular carcinoma: a randomized controlled trial. Ann Surg 2015; 261: 56-66.

Published: 14th April 2015

Authors: Huang G, Lau WY, Wang Z-G, Pan Z-Y, Yuan S-X, Feng S et al. et al.


In this study that included 200 patients, antiviral therapy reduced the rate of recurrence-free survival (46.1 versus 27.1 per cent, P=0.026) and overall survival (63.1 versus 41.5 per cent, P=0.001).

Pubmed Link

Your comments